ストックスクリーナーアプリを入手
0.236
2.88%
0.0066
アフターアワーズ：
.24
0.004
+1.69%
前日終値:
$0.2294
開ける：
$0.2282
24時間の取引高:
812.15K
Relative Volume:
0.06
時価総額：
$9.86M
収益：
$20.27M
当期純損益:
$-63.80M
株価収益率:
-0.1553
EPS:
-1.52
ネットキャッシュフロー:
$-68.35M
1週間 パフォーマンス:
-19.18%
1か月 パフォーマンス:
-38.80%
6か月 パフォーマンス:
-47.58%
1年 パフォーマンス:
-80.17%
1日の値動き範囲:
$0.2146
$0.2432
1週間の範囲:
$0.2102
$0.3067
52週間の値動き範囲:
$0.1417
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
名前
Carisma Therapeutics Inc
セクター
電話
(267) 491-6422
住所
3675 MARKET STREET, PHILADELPHIA
CARM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.236 | 11.66M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-04-11 | 開始されました | BTIG Research | Buy |
| 2023-10-03 | 開始されました | CapitalOne | Overweight |
| 2023-07-06 | 開始されました | Evercore ISI | Outperform |
| 2023-05-31 | アップグレード | Jefferies | Hold → Buy |
| 2023-05-24 | 開始されました | H.C. Wainwright | Buy |
| 2023-04-14 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Carisma Therapeutics Inc (CARM) 最新ニュース
Has Carisma Therapeutics Inc. formed a bullish divergenceWatch List & Reliable Price Breakout Alerts - Newser
Carisma Therapeutics Inc. recovery potential after sell offRisk Management & Technical Pattern Alert System - Newser
Building trade automation scripts for Carisma Therapeutics Inc.July 2025 Reactions & Daily Profit Focused Stock Screening - Newser
Visual analytics tools that track Carisma Therapeutics Inc. performanceEarnings Recap Summary & Weekly High Return Stock Opportunities - Newser
Full technical analysis of Carisma Therapeutics Inc. stock2025 Valuation Update & High Accuracy Trade Alerts - Newser
Carisma Therapeutics Inc. stock prediction for this weekMarket Sentiment Report & Short-Term High Return Strategies - Newser
Applying chart zones and confluence areas to Carisma Therapeutics Inc.Weekly Gains Report & Reliable Intraday Trade Plans - Newser
Carisma Therapeutics Inc. (NASDAQ:CARM) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
What earnings revisions data tells us about Carisma Therapeutics Inc.2025 Technical Overview & Verified Trade Idea Suggestions - Newser
Applying big data sentiment scoring on Carisma Therapeutics Inc.July 2025 Sector Moves & Weekly Market Pulse Updates - Newser
What makes Carisma Therapeutics Inc. stock price move sharplyWeekly Stock Recap & Growth Focused Stock Reports - newsyoung.net
How to forecast Carisma Therapeutics Inc. trends using time seriesTrade Volume Report & AI Powered Buy/Sell Recommendations - Newser
Top Risks to Consider Before Buying Carisma Therapeutics Inc. StockEarnings Summary Report & Reliable Intraday Trade Alerts - Newser
Chart based analysis of Carisma Therapeutics Inc. trendsRate Hike & High Return Stock Watch Alerts - Newser
How Carisma Therapeutics Inc. stock performs during market volatilityMarket Weekly Review & Safe Capital Growth Tips - Newser
Can Carisma Therapeutics Inc. Overcome Bearish SentimentTrade Volume Summary & Free Long-Term Investment Growth Plans - sundaytimes.kr
Carisma Therapeutics Inc. stock outlook for YEAR2025 Growth vs Value & Consistent Income Trade Recommendations - Newser
Published on: 2025-08-17 17:18:40 - beatles.ru
Pattern recognition hints at Carisma Therapeutics Inc. upside2025 Institutional Moves & Community Consensus Picks - Newser
Using Ichimoku Cloud for Carisma Therapeutics Inc. technicalsWeekly Investment Summary & Daily Volume Surge Trade Alerts - Newser
Will earnings trigger a reversal in Carisma Therapeutics Inc.Portfolio Value Report & Stock Portfolio Risk Control - Newser
Is Carisma Therapeutics Inc. stock bottoming out2025 Market Sentiment & Consistent Income Trade Ideas - Newser
Carisma Therapeutics (NASDAQ:CARM) versus Crinetics Pharmaceuticals (NASDAQ:CRNX) Critical Analysis - Defense World
Will Carisma Therapeutics Inc. Sustain Its Chart Breakout2025 Big Picture & Real-Time Chart Pattern Alerts - beatles.ru
Investors Hope for Bounce in Carisma Therapeutics Inc. After Selloff2025 Sector Review & Daily Stock Momentum Reports - sundaytimes.kr
Is This the Dip to Buy in Carisma Therapeutics Inc.Market Risk Report & Consistent Return Strategy Ideas - sundaytimes.kr
Trendlines Suggest Carisma Therapeutics Inc. May Bottom Out SoonProduct Launch & High Conviction Buy Zone Picks - beatles.ru
Is this a good reentry point in Carisma Therapeutics Inc.Forecast Cut & AI Based Buy and Sell Signals - Newser
Buy Signal for Carisma Therapeutics Inc. Stock Key Technical Indicators to WatchFree Risk-Adjusted Picks With Exit Strategy - Newser
Carisma Therapeutics Approves Reverse Stock Split - The Globe and Mail
Carisma Therapeutics (CARM) Projected to Post Quarterly Earnings on Thursday - Defense World
CARISMA Therapeutics 2025 Q1 Earnings Loss Narrows by 51.2% - AInvest
CARISMA Therapeutics: D. Boral Capital maintains Buy, PT raised to $1 from $0.90 - AInvest
Carisma Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Carisma Therapeutics Inc. (NASDAQ:CARM) - Defense World
Carisma Therapeutics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Is it the right time to buy Carisma Therapeutics Inc. stockFree Market Volatility Navigation Tips - Jammu Links News
Is Carisma Therapeutics Inc. a good long term investmentCapitalize on market momentum for maximum gains - Jammu Links News
How many analysts rate Carisma Therapeutics Inc. as a “Buy”Capitalize on emerging investment opportunities - Jammu Links News
Why is Carisma Therapeutics Inc. stock attracting strong analyst attentionExplosive capital appreciation - Jammu Links News
Carisma Therapeutics Inc (CARM) 財務データ
収益
当期純利益
現金流量
EPS
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):